1. Discuss the anatomy, pathophysiology and progression of COPD Chronic obstructive pulmonary disease (COPD) includes the illnesses; emphysema, chronic bronchitis and chronic asthma – separately or in conjunction with each other. COPD can be caused by smoking cigarettes, long-term exposure to pollutants or irritants (such as chemicals) or genetics factors. The lower respiratory system contains the lower trachea, bronchi, bronchioles and alveoli in the lungs. The bronchi form as the lower part of
Defining what COPD is- COPD is involved in two types of diseases that most people don’t know are related. For example: bronchitis and emphysema are a related source of COPD. They are both involved into a chronic obstructive of the airflow. This does come out of the human body’s lungs. Many don’t know that they are both a very permanent but can be progressive over time. Asthma is also another one of the pulmonary disease’s which also causes the obstruction of the airway (airflow) that comes out of
presence of airflow obstruction which is largely irreversible is a major feature of COPD. It is proposed to be the result of a combination of small airways narrowing, airway wall inflammation [89] and emphysema-related loss of lung elastic recoil [1, 90, 91]. The pathologic features of COPD are structural changes of the lung, including emphysema and small airway remodelling [92]. Small airway remodelling in COPD is characterized by adventitial fibrosis and mucus cell hyperplasia, and may involve
Chronic Obstructive Pulmonary Disease (COPD) When you breath, air travels through tubes in your lungs to millions of tiny air sacs. In a healthy and functioning lung, the airways are open and the air sac fill up with air. Then the air goes back out quickly. COPD makes it hard to get air through the airways and into and out of the air sacs. COPD includes both Chronic Bronchitis and Emphysema. Chronic bronchitis is increased cough and mucus production caused by inflammation of the airways. Emphysema
Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema, are a leading cause of morbidity and death worldwide. Asthma, a chronic disease that involves inflammation of the airways, bronchoconstriction, and intermittent (usually reversible) airflow obstruction, also affects numerous individuals worldwide. Both COPD and asthma are common obstructive lung disorders that affect over 49 million people in the US (1). While the pathology of asthma and COPD are distinct, both diseases
CC: Followed up COPD. History of Present Illness: Mr. Magnuson is a very pleasant 77-year-old gentleman who was previously seen in this office by Elvira Aguila, MD for COPD and hypoxic respiratory failure. He is here today for routine followed up. He was last evaluated in January 2015. Since that time, he states that his dyspnea is worse. He feels that it is related to the weather. He does state that he works around the house, although he does have significant functional limitations because
second-hand smoke. However, children, teenagers and young adults who are not fully developed when it comes to their lung capacity, might suffer even more, risking various diseases, including COPD. WHAT IS COPD? Chronic obstructive pulmonary disease (COPD) (http://www.thehealthsite.com/diseases-conditions/copd/001/) is considered one of the most common causes of death in the world today and, it appears that most of the patients are active smokers. However, according to researchers, the pulmonary
Background Information Encompassed primarily by two conditions, emphysema and chronic bronchitis, Chronic Obstructive Pulmonary Disease (COPD) refers to a group of diseases of a debilitating and progressive nature that cause inflammation of the airway and interferes with the ability to breathe (National Heart, Lung, and Blood Institute [NHLBI], 2013). The diseases in COPD have some shared characteristics, including a progressive and irreversible limitation of the airflow associated with an abnormal inflammation
Canadian population, dementia as a serious public health issue will continue to grow. Several research reports point to a potential link between COPD and the development of cognitive decline.[2-5] Depending on the population group and methodology, about 10 to 61% of COPD patients have cognitive impairment.[2,6] The literature indicates that cognitive impairment in COPD patients may be associated with increased adverse outcomes such as more prolonged hospitalization, difficulty with the instrumental activities
realising the burden COPD has on general New Zealand population ,affecting about15% of the adult population over the age of 45 years according to asthmanz( 2010) ,l took this case study to gain in-depth understanding. Presenting hx Chari is a known patient with Chronic obstructive airway disease(COPD).He presented with